Left heart abnormalities in connective tissue disease patients with pre-capillary pulmonary hypertension as well as borderline mean pulmonary arterial pressure

被引:1
|
作者
Tsuchida, Kosei [1 ]
Yamada, Hidehiro [1 ]
Yamasaki, Yoshioki [1 ]
Suzuki, Kengo [2 ]
Kongoji, Ken [2 ]
Akashi, Yoshihiro
Ozaki, Shoichi [1 ]
机构
[1] St Marianna Univ, Sch Med, Div Rheumatol & Allergol, Dept Internal Med,Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan
[2] St Marianna Univ, Sch Med, Div Cardiol, Dept Internal Med,Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan
关键词
Connective tissue disease; Borderline mPAP; Diastolic dysfunction; Left heart abnormalities; Pre-capillary pulmonary hypertension; SYSTEMIC-SCLEROSIS; ECHOCARDIOGRAPHY; DIAGNOSIS; EXERCISE; GRADIENT;
D O I
10.3109/14397595.2015.1005871
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To describe co-existence of left heart abnormalities among case series of connective tissue disease (CTD) patients who showed pre-capillary pulmonary hypertension (PH) as well as borderline mean pulmonary arterial pressure (mPAP). Methods. From 2010 through 2012, 49 CTD patients suspected to have PH by exercise Doppler echocardiography underwent right heart catheterization. We retrospectively searched for left heart diseases from the available data on Doppler echocardiography, cardiac magnetic resonance imaging (MRI), scintigraphy, and endomyocardial biopsy. Results. Among 49 patients, 11 and 2 had pre- and post-capillary PH, respectively, and another 10 had borderline mPAP. Six of 11 patients with pre-capillary PH showed low pulmonary vascular resistance (PVR) (<= 240 dynes.sec.cm(-5)) and low diastolic pulmonary gradient (< 7 mmHg). Seven of 10 patients with borderline mPAP had normal PVR (< 160) suggesting the presence of left heart abnormalities. Other abnormal findings included increased left atrial volume index and E/E'on Doppler echocardiography, delayed contrast enhancement by MRI, patchy area of hypoperfusion on thallium scintigraphy, and fibrosis in endomyocardial biopsy. Conclusion. The present case series suggested some contribution of left heart abnormalities to the increase in mPAP among CTD patients with pre-capillary PH as well as borderline mPAP.
引用
收藏
页码:744 / 747
页数:4
相关论文
共 50 条
  • [21] Diversity of hemodynamic types in connective tissue disease associated pulmonary hypertension: more than a subgroup of pulmonary arterial hypertension
    Dong, Xingbei
    Shi, Yue
    Xia, Ying
    Zhang, Xiao
    Qian, Junyan
    Zhao, Jiuliang
    Peng, Jinmin
    Wang, Qian
    Weng, Li
    Li, Mengtao
    Du, Bin
    Zeng, Xiaofeng
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [22] Pulmonary vasodilators in patients with advanced chronic kidney disease and pre-capillary pulmonary hypertension-A case series
    Leguizamon, Raul
    Mclaren, Ian
    John, Tara
    Khan, Rasha
    Prendergast, Alexander
    Wattanachayakul, Phuuwadith
    Geller, Andrew
    Malin, John
    Jarret, Simone A.
    Lo, Kevin Bryan
    Manzano, Jose Manuel Martinez
    Witzke, Christian
    RESPIROLOGY CASE REPORTS, 2024, 12 (09):
  • [23] Recent developments in connective tissue disease associated pulmonary arterial hypertension
    Rodolfi, Stefano
    Ong, Voon H.
    Denton, Christopher P.
    INTERNATIONAL JOURNAL OF CARDIOLOGY CONGENITAL HEART DISEASE, 2024, 16
  • [24] Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study
    Takahashi, Kota
    Taniguchi, Hiroyuki
    Ando, Masahiko
    Sakamoto, Koji
    Kondoh, Yasuhiro
    Watanabe, Naohiro
    Kimura, Tomoki
    Kataoka, Kensuke
    Suzuki, Atsushi
    Ito, Satoru
    Hasegawa, Yoshinori
    BMC PULMONARY MEDICINE, 2016, 16
  • [25] Survival of connective tissue disease associated pulmonary arterial hypertension
    Luppino Assad, A. P.
    Gavilanes Oleas, F.
    Alves, J. L., Jr.
    dos Santos Fernandes, C. J. C.
    Sampaio-Barros, P. D.
    Souza, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : S186 - S186
  • [26] Sildenafil for pulmonary arterial hypertension associated with connective tissue disease
    Badesch, David B.
    Hill, Nicholas S.
    Burgess, Gary
    Rubin, Lewis J.
    Barst, Robyn J.
    Galie, Nazzareno
    Simonneau, Gerald
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (12) : 2417 - 2422
  • [27] Cardiac Catheterization versus Echocardiography for Monitoring Pulmonary Pressure: A Prospective Study in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
    Bournia, Vasiliki Kalliopi
    Tsangaris, Iraklis
    Rallidis, Loukianos
    Konstantonis, Dimitrios
    Frantzeskaki, Frantzeska
    Anthi, Anastasia
    Orfanos, Stylianos E.
    Demerouti, Eftychia
    Karyofillis, Panagiotis
    Voudris, Vassilis
    Laskari, Katerina
    Panopoulos, Stylianos
    Vlachoyiannopoulos, Panayiotis G.
    Sfikakis, Petros P.
    DIAGNOSTICS, 2020, 10 (01)
  • [28] Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension
    Kularatne, Mithum
    Boucly, Athenais
    Savale, Laurent
    Solinas, Sabina
    Cheron, Celine
    Roche, Anne
    Jevnikar, Mitja
    Jais, Xavier
    Montani, David
    Humbert, Marc
    Sitbon, Olivier
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2101 - 2115
  • [29] The Role of Pulmonary Artery Wedge Pressure on the Incidence of Atrial Fibrillation and Atrial Tachycardias in Patients With Isolated Pre-capillary Pulmonary Hypertension
    Dusik, Milan
    Fingrova, Zdenka
    Ambroz, David
    Jansa, Pavel
    Linhart, Ales
    Havranek, Stepan
    PHYSIOLOGICAL RESEARCH, 2021, 70 (06) : 841 - 849
  • [30] Simplified risk stratification for pulmonary arterial hypertension associated with connective tissue disease
    Li, Xiaodi
    Sun, Xiaoxuan
    Huang, Yingheng
    Wang, Yuanyuan
    Yang, Xiaoman
    Wang, Jingya
    Zhang, Ning
    Gu, Lei
    Zhang, Miaojia
    Wang, Qiang
    CLINICAL RHEUMATOLOGY, 2019, 38 (12) : 3619 - 3626